bay36-7620 and Schizophrenia

bay36-7620 has been researched along with Schizophrenia* in 1 studies

Reviews

1 review(s) available for bay36-7620 and Schizophrenia

Article	Year
[Pharmacological characterization of metabotropic glutamate-receptor 1 antagonist for the treatment of schizophrenia]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2013, Volume: 142, Issue:6 Topics: Animals; Benzimidazoles; Drug Discovery; Humans; Isoindoles; Mice; Molecular Targeted Therapy; Naphthalenes; Protein Binding; Rats; Receptors, Metabotropic Glutamate; Schizophrenia; Thiazoles; Triazoles	2013

Article

Year

[Pharmacological characterization of metabotropic glutamate-receptor 1 antagonist for the treatment of schizophrenia].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2013, Volume: 142, Issue:6

Topics: Animals; Benzimidazoles; Drug Discovery; Humans; Isoindoles; Mice; Molecular Targeted Therapy; Naphthalenes; Protein Binding; Rats; Receptors, Metabotropic Glutamate; Schizophrenia; Thiazoles; Triazoles

2013